M.I.N.D. Pharmaceuticals' Incubator/Accelerator Round

M.I.N.D. Pharmaceuticals raised a round of funding on June 13, 2017. Investors include i.Lab at UVA.

M.I.N.D. Pharmaceuticals is developing medicine based on natural biological nanoparticles for disease treatment and non-invasive diagnostics for early detection, as well as skincare/beauty products.…

Articles about M.I.N.D. Pharmaceuticals' Incubator/Accelerator Round: